Disparities exist in treatment, survival among black, white men with early stage breast cancer

the ONA take:

In this study, the researchers investigated the disparities between blacks and whites in receipt of treatment for early stage breast cancer in men age 18 to 64 years and men 65 years and older.

The study included 725 non-Hispanic black (black) and 5,247 non-Hispanic white (white) men with a diagnosis of early stage breast cancer from 2004 to 2011 in the National Cancer Data Base.

Receipt of treatment was found to be remarkably similar between blacks and whites in both age groups. In both races, fewer older men received chemotherapy compared with younger men.

Risk of death, however, was higher for the younger black men than the younger white men, but the difference was significantly less after adjustments for covariates. That risk was not significant and not affected by covariates in the groups of older men.

Higher risk of death in black men vs white men is limited to men age 18 to 64 years and became nonsignificant after adjustments for insurance and income.

The researchers conclude that improving access to care is an important factor in reducing the disparities in male breast cancer mortality.

Disparities exist in treatment, survival among black, white men with early stage breast cancer
Researchers investigated the disparities between blacks and whites in receipt of treatment for early stage breast cancer.
The excess risk of death in black versus white men diagnosed with early-stage breast cancer was largely confined to those age 18 to 64 years and became nonsignificant after adjustment for differences in insurance and income.
READ FULL ARTICLE From Ascopubs
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs